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ABSTRACT 
Currently licensed typhoid vaccines are based on Vi capsular polysaccharides. Recent molecular reports from 
typhoid endemic countries state that Salmonella enterica serovar Typhi (S. Typhi) Vi negative strains occur nat-
urally and cause typhoid fever which is indistinguishable from disease caused by Vi positive strains. Vaccine 
based on Vi polysaccharide may not protect patients if the invading S. Typhi are negative for Vi. The lipopoly-
saccharide (LPS) is an essential component of S. Typhi outer membrane in which O-specific polysaccharide 
(OSP) is a protective antigen and universal candidate for vaccine development. In this study, S. Typhi Vi nega-
tive isolates were discriminated from Vi positive isolates through a duplex PCR using primers of fliC-d (599bp) 
and tviA (495bp) genes. The LPS of S. Typhi Vi negative isolates was extracted by hot phenol method and OSP 
was purified by core hydrolysis. The yield of extracted LPS was 91 mg/L and that of purified OSP was 
49.14 mg/L of culture broth. LPS showed ladder like appearance by zinc imidazole staining following SDS-
PAGE. Whole cell challenged mice sera were used for in vitro antigenicity evaluation of the purified LPS and 
OSP. The antigenicity was found adequate by immunodiffusion assay. To our knowledge, this is the first report 
of purification and antigenic evaluation of LPS of a Vi negative S. Typhi isolate. The purified OSP from S. 
Typhi Vi negative isolate may be coupled with a carrier protein to produce universal low cost conjugate vaccine 
candidates for use in typhoid endemic regions.  
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INTRODUCTION 
Generally typhoid fever is caused by S. 
Typhi Vi positive strains (STVP). However, 
S. Typhi Vi negative (STVN) strains which 
are emerging rapidly, can also contribute to 
this ailment (Baker et al., 2005; Wain et al., 
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2005; Pulickal et al., 2013). In some Asian 
countries, particularly Nepal and Pakistan, 
STVN strains exist in nature frequently 
(Baker et al., 2005; Pulickal et al., 2013). 
Molecular studies have indicated that STVN 
isolates may not be agglutinated by anti-Vi 
sera (Arya, 2002). These STVN isolates 
were identified during phage typing in vari-
ous geographical locations as earlier as 
1960s (Baker et al., 2005). Even before these 
recent findings, a positive selection pressure 
on S. Typhi was observed, which down-
regulated or stopped the expression of Vi 
subunit (Arya, 2002). The expression of Vi 
capsule may not be crucial for infection in 
humans as STVN mutants and vaccine 
strains infect human volunteers and provoke 
immune response in them (Hone et al., 1988; 
Pulickal et al., 2013). These observations 
could have implications regarding the effica-
cy of the Vi based vaccine in typhoid endem-
ic countries as well as for the conjugate vac-
cines based on Vi-proteins that are currently 
undergoing clinical trials for use in pediatric 
populations (Lin et al., 2001; Pulickal et al., 
2013). 
Lipopolysaccharide (LPS) is an essential 
structural component of the outer cell mem-
brane of Salmonella species like other Gram 
negative bacteria. LPS plays a crucial role in 
pathogenesis in humans (Raetz and 
Whitfield, 2002). OSP antigen is universally 
present both in Vi positive and Vi negative 
strains (Arya and Agarwal, 2014). OSP of 
the LPS of S. Typhi is a protective antigen 
and has been used as a target for vaccine de-
velopment (Ali et al., 2012).  
Most of the previous work has been done 
on Vi positive S. Typhi isolates but this 
study was focused on purification and anti-
genic evaluation of OSP from a local Vi 
negative S. Typhi isolate. 
 
MATERIALS AND METHODS 
Bacterial isolates and biochemical identifi-
cation  
Two S. Typhi isolates (AS1 and AS7) 
were taken from National Institute for Bio-
technology and Genetic Engineering (NIB-
GE) stock cultures, inoculated (50 µL) in 
3 mL of tryptic soya broth (TSB, Merck, 
Germany) 30 g/liter (w/v) and incubated at 
37 °C overnight. Subculture was done on a 
separate MacConkey agar plate (65 g/liter 
[w/v]) and incubated at 37 °C overnight. A 
single colony was transferred to triple sugar 
iron (TSI) agar slant to identify the S. Typhi. 
For biochemical identification of S. Typhi, 
Remel kit (RapID ONE) (Thermo Fisher 
Scientific, Lenexa, USA) was used accord-
ing to the manufacturer’s instructions. The 
results obtained were interpreted using soft-
ware ERIC (Electronic RapID Compendi-
um), (Thermo Fisher Scientific, Lenexa, 
USA). 
 
Molecular identification of S. Typhi Vi 
negative isolate 
Total genomic DNA of biochemically 
identified S. Typhi was isolated as already 
described (Haque et al., 2001). Duplex PCR 
was performed according to protocol men-
tioned earlier (Baker et al., 2005). Two sets 
of primers: fliC-F/fliC-R was used for ampli-
fication of fliC-d gene and Vi-F/Vi-R (Table 
1) was used to amplify tviA gene, present on 
viaB operon. The fliC-d gene was used as a 
signature sequence for the confirmation of S. 
Typhi while tviA gene was used to differen-
tiate STVP and STVN isolates.  
 
Fermentation of Vi negative S. Typhi 
Confirmed STVN (AS7) isolate was 
grown in a 20 L fermenter (Biostat®C, USA) 
containing 12 L TSB and 10 % (v/v) inocu-
lum. Fermentation was carried out at 32 °C 
and pH 6.7 with stirring at 400 rpm for 11 
hours. After 7 hours, growth was supple-
mented with 25 % sterilized glucose solution 
to enhance the carbohydrate yield. Bacterial 
cells were killed using 1 % formalin. Stirring 
was continued at 200 rpm overnight and bac-
teria were harvested by centrifugation at 
7,000 x g at 4 °C for 40 min. 
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Table 1: Primers used in duplex PCR for Vi negative S. Typhi identification  
Primers Sequences (5/ - 3/) Genes Amplicons 
(bp)
References 
fliC-F  
fliC-R 
TATGCCGCTACATATGATGAG 
TTAACGCAGTAAAGAGAG 
fliC 495 Song et al.,1993 
Vi-F 
Vi-R 
GTTATTTCAGCATAAGGAG  
ACTTGTCCGTGTTTTACTC 
tviA 599 (Hashimoto et al., 1995) 
 
 
 
Purification of lipopolysaccharides (LPS) 
from S. Typhi 
LPS was extracted from STVN by hot-
phenol method as mentioned earlier (West-
phal et al., 1965). Briefly, the S. Typhi sus-
pension (1 g of wet pellet per 10 mL of dis-
tilled water) was mixed with 90 % phenol 
(equilibrated at 68 °C) and incubated at the 
same temperature using inverted stirrer for 
30 min. Temperature of the mixture was 
lowered to 10 °C using ice to enable the sep-
aration of phases followed by centrifugation 
at 7300 x g for 50 min at 10 °C. The upper 
clear aqueous layer was collected. The 
amount of water (equal to the collected water 
layer) was added to the lower layer and the 
mixture was again stirred at 68 °C for 
30 min, cooled to 10 °C and centrifuged at 
7300 x g for 50 min. The two water layers 
were combined and re-centrifuged at 8000 
x g for 50 min. The upper layer was collect-
ed and precipitated contaminants were dis-
carded. The water layer was adjusted to con-
tain 10 mM sodium acetate, 2 mM calcium 
chloride and 25 % ethanol, and incubated at 
4 °C overnight. The suspension was centri-
fuged at 14,300 x g at 10 °C for 60 min to 
precipitate the nucleic acids. To precipitate 
the LPS, 75 % ethanol was added to superna-
tant, mixed at room temperature for 20 min 
and kept at 4 °C overnight. The supernatant 
was removed by centrifugation at 7,300 x g 
for 60 min at 4 °C.The pellet was dissolved 
in appropriate amount of deionized distilled 
water and dialyzed (cut off 6,000 – 8,000) 
for 2 days against deionized distilled water 
with 2 water changes per day. The dialyzed 
pellet was lyophilized and named as crude 
LPS. The crude LPS were dissolved in de-
ionized distilled water, dispensed into a dial-
ysis tube and equilibrated against buffer 
(2 mM MgSO4, 50 mMTris-Cl, pH 7.6) at 
37 °C for 2 hours. After equilibration, DNase 
(200 µg/mL) and RNase (50 µg/mL) were 
added whereas proteinase K (200 µg/mL) 
was added after 6 hours. The mixture was 
further dialysed overnight at 37 °C. Next 
day, the dialysis buffer was replaced with 
deionized water and dialysis was continued 
at 4 °C for 2 days with 2 water changes per 
day. The dialyzed suspension was centri-
fuged at 5500 rpm for 30 min, pellet was 
discarded and the supernatant was ultracen-
trifuged at 96,000 x g for 5 hours at 4 °C. 
The pellet was lyophilized as purified LPS. 
For nucleic acid estimation, the LPS was dis-
solved in 1 % sodium dodecyl sulfide solu-
tion (1 mg/mL) and scanned at 260 nm using 
1 % SDS as blank solution. The nucleic ac-
ids concentration was analyzed. 
 
Purification of O-specific polysaccharides 
Core hydrolysis of the purified LPS was 
done for OSP extraction as described earlier 
(Ali et al., 2012; Chu et al., 1991). Briefly, 
the purified LPS were dissolved at 10 mg/ 
mL in 1 % glacial acetic acid and placed in a 
reaction-block at 100 °C for 90 min. The 
mixture was cooled to ambient temperature; 
distributed in Corex tubes and centrifuged at 
8000 x g for 20 min. Supernatant was passed 
through a chromatography column using G-
25 Sephadex (Amersham Biosciences, 
USA). The void volume fractions were 
pooled in a round bottom flask, frozen with 
dry ice and lyophilized. The nucleic acid and 
protein concentration was analyzed as men-
tioned earlier (Chu et al., 1991). The purified 
OSP was stored at -20 °C.  
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Immunodiffusion assay of purified LPS 
and OSP 
One percent agarose gel was used for 
immunodiffusion assay (Ouchterlony, 1986) 
and the assay was performed on glass slides. 
Hyper immune sera were raised by injecting 
mice for 3 consecutive weeks with 3 injec-
tions per week of the formalin killed S. 
Typhi whole cells (Ali et al., 2012). Heart 
bleeding was done after one week of the last 
injection and the serum was separated and 
used for the immunodiffussion assay.  
 
RESULTS 
Biochemical identification of S. Typhi 
AS1 and AS7 showed smooth, transpar-
ent, round (2-3 mm) and moist colonies on 
MacConkey agar plates. On TSI agar slants, 
the S. Typhi isolates produced yellow pig-
ment in butt (due to acid production) and 
showed pink slant surface (due to alkali pro-
duction). Small amount of blackening of the 
medium was observed due to H2S produc-
tion. However, no gas production was re-
corded. These typical biochemical reactions 
as well as characteristic reactions on Remel 
kit (Thermo Fisher Scientific, Lenexa, USA) 
observations identified both of the isolates as 
S. Typhi. 
 
Duplex PCR for confirmation of Vi  
negative S. Typhi isolate 
Duplex PCR resulted in amplified prod-
ucts of both fliC-d (495 bp) and tviA (599 
bp) gene fragments for STVP isolate (AS1), 
while for STVN (AS7), amplification of only 
fliC-d (495 bp) gene fragment was seen. No 
PCR amplification was found in case of ne-
gative controls. This molecular analysis con-
firmed AS7 as STVN isolate (Figure 1). 
 
Purification of lipopolysaccharides (LPS) 
from S. Typhi 
STVN AS7 isolate when grown in fer-
menter, yielded 18.18 g of wet pellet per liter 
of culture. LPS were extracted and purified 
from the cell pellet at a concentration of 
91 mg of purified LPS per liter culture. In 
crude LPS, nucleic acid contamination was 
found as 9.38 % while the protein impurities 
were detected to be 9.78 %. The nucleic acid 
and protein impurities were reduced to 
0.06 % and 0.07 % respectively by treatment 
of DNase, RNase and protease (Table 2). 
The purified LPS were checked on SDS-
PAGE followed by zinc-imidazole staining, 
which showed characteristic multiple repeti-
tive band pattern (Figure 2). 
 
 
Figure 1: S. Typhi genomic DNA of Vi positive 
and Vi negative isolates were amplified using 
duplex PCR Lane 1; primers of fliC and Vi genes 
were amplifed from Vi positive isolate, Lane 2; 
only fliC gene was amplified from Vi negative 
isolate. Lane 3; negative control that did not 
show any result. Lane M denotes 100 bp DNA 
ladder (Fermentas Cat No. SM323). 
 
 
Purification of O-specific polysaccharides 
(OSP) of S. Typhi 
Sephadex G-25 size exclusion chroma-
tography of core hydrolyzed LPS resulted in 
lipid A removal and yielded the purified 
OSP as 49.14 mg/L yield of OSP (54 % OSP 
from purified LPS) (Figure 3). The nucleic 
acid and protein contaminations were found 
as 0.04 % and 0.03 % respectively (Table 2). 
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Table 2: Nucleic acid and protein concentration in Vi negative S. Typhi LPS 
Sample Yield/L 
 
 
Nucleic acid  
concentration
Protein 
concentration 
Pre nuclease 
treatment 
Post  
nuclease 
treatment 
Pre 
protease 
treatment 
Post  
protease 
treatment 
S. Typhi 
Vi negative LPS 
91 mg/liter 9.38 % 0.06 % 9.78 % 0.07 % 
 
S. Typhi 
Vi negative OSP 
49.14 mg/liter N/A 0.04 % N/A 0.03 % 
 
 
 
Figure 2: Lane 1-4 contain 2, 1, 0.5 and 0.25 
mg/mL of S. Typhi Vi negative LPS respectively 
followed by Zinc imidazole stain. Due to repeti-
tive sugars concentration the LPS shows ladder 
like structure instead of a single band. 
 
 
 
Figure 3: Sephadex G-25 size exclusion chro-
matography column for purification of O-specific 
polysaccharide (OSP) of S. Typhi Vi negative 
using phosphate buffer saline (PBS) citrate as 
mobile phase. X-axis shows tube number and Y- 
axis denotes refractive index. 
Antigenicity evaluation of purified LPS and 
OSP 
The immunodiffusion assay showed a 
clear precipitin line between antigens (LPS/ 
OSP) and antibodies (Figure 4) which con-
firmed that LPS/OSP were antigenically ac-
tive and can further be used for conjugation 
with carrier protein to make potential immu-
nogenic conjugate vaccine candidates. 
 
 
Figure 4: To determine the antigen antibody in-
teraction in vitro, LPS of S. Typhi Vi negative and 
mice serum (polyclonal antibodies) were loaded 
on 1 % agarose immunodiffusion gel. Well 1 and 
3 shows 1 mg/mL and 0.5 mg/mL LPS in 1 N 
saline respectively, while well 2 shows 1/8 time 
diluted polyclonal antibodies. 
 
 
DISCUSSION 
Vi capsular polysaccharide of S. Typhi is 
encoded on a region of the bacterial genome 
called viaB operon which is located on the 
Salmonella Pathogenicity Island-7 (SPI-7) 
that consists of 10 genes: 5 coding for the 
synthesis of the polysaccharide capsule (tviA, 
tviB, tviC, tviD, tviE) and 5 coding for the 
polysaccharide transportation proteins (vexA, 
vexB, vexC, vexD, vexE) (Pickard et al., 
2003). Earlier studies have confirmed the 
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expression of Vi capsular polysaccharide 
gene. On these basis, it is easy to confirm 
STVN isolates (Maurya et al., 2010). 
Generally, it is assumed that the onset of 
typhoid fever in humans is because of Vi an-
tigen (Wetter et al., 2012). On the contrary, 
typhoid fever may be caused by naturally 
occurring STVN strains having similar 
symptoms as caused by STVP strains. In a 
study from Faisalabad, Pakistan, 60 fresh 
isolates from typhoid patients’ blood were 
examined and 9 (15 %) were found negative 
for both tviA and tviB genes (Baker et al., 
2005). In India, 10 % of freshly isolated 
strains were also found to be negative for Vi 
agglutination (Maurya et al., 2010). Very 
recently the prevalence of STVN isolates 
was confirmed in children from Kathmandu, 
Nepal. Out of sixty eight isolates, 5.9 % of 
total isolates were found negative for capsu-
lar expression through slide agglutination 
tests (Pulickal et al., 2013). Suppression of 
Vi expression enhances the capability of  S. 
Typhi invasion in the intestine and facilitate 
the destruction within Peyer’s patches (Zhao 
et al., 2001). There are few reports for differ-
entiating STVP and STVN isolates but they 
need use of a large number of primers. This 
method is a simple duplex PCR. 
Vaccine based on Vi polysaccharide will 
not protect patients if the invader S. Typhi is 
negative for Vi (Senthilkumar et al., 2014). 
So it is imperative to target antigens which 
are universally present in all S. Typhi. Lipo-
polysaccharides (LPS) of outer cell mem-
brane have been identified as having poten-
tial for development of vaccines effective 
against all S. Typhi isolates. In LPS, Lipid A 
is a toxic constituent, while OSP chains play 
an important role in resistance to serum bac-
tericidal action and phagocytosis (Raetz and 
Whitfield, 2002). It is important to remove 
Lipid A. To date, there is no report of extrac-
tion of LPS and purification of OSP from 
STVN isolates. During this study, LPS was 
extracted from STVN by using the Westphal 
method. Impurities of nucleic acid and pro-
teins from the extracted LPS were reduced 
up to 99 %. Furthermore, passing the puri-
fied OSP through Sephadex G-25 removed 
the residues of enzymes. The obtained yield 
of purified OSP was 49.14 mg/L (Table 2). 
In the immunodiffusion reaction, clear 
precipitin lines were obtained using LPS/ 
OSP concentrations of 1 mg/mL and up to a 
1/8 dilution of the mice serum containing 
IgG antibodies. No positive reactions were 
observed with normal saline control. 
This is the first report of purification and 
antigenic evaluation of OSP from STVN. 
The purified OSP can be used in preparation 
of universal vaccine candidates after conju-
gation with a carrier protein.  
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